BRITTANY JORGENSEN: Open Payments
NPI 1932685500 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 67 payments from 24 companies in 2025. Trend: 2023 $968 · 2024 $1,098 · 2025 $1,615
Food & beverage: $1,281Consulting: $335
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 11 | $516 |
| ABBVIE INC. | 6 | $115 |
| Phathom Pharmaceuticals, Inc. | 6 | $84 |
| Cycle Pharmaceuticals Inc | 3 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Corcept Therapeutics | 3 | $69 |
| CSL Behring | 2 | $59 |
| Lundbeck LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
Products named: Quzyttir, REXULTI, VOQUEZNA, Sajazir, CAPLYTA, Jornay PM, Korlym, Dyanavel XR.
Industry payments across UT — which companies pay providers there.
